Tofacitinib Linked to Esophageal Pressure Changes in Systemic Sclerosis Cohort
In a retrospective controlled cohort of patients with systemic sclerosis, add-on tofacitinib was independently associated with increased resting lower esophageal ...
In a retrospective controlled cohort of patients with systemic sclerosis, add-on tofacitinib was independently associated with increased resting lower esophageal ...
Clinicians report that targeting the type I interferon pathway with tofacitinib induced complete remission in a patient with treatment-resistant full-house ...
A German Embryotox observational cohort found two major congenital anomalies among 32 live births after first-trimester JAK inhibitor exposure, but ...
A 28-day animal study reports dose-dependent blood pressure reductions, decreased CPK-MB, increased basilar artery tone, and nonlinear mortality in tofacitinib-treated ...
A new case report describes how two years of unexplained, mildly elevated liver enzymes in a nine-year-old boy ultimately pointed ...
A case report from Zhongshan Hospital describes how early second-line immunosuppression with tofacitinib and mycophenolate mofetil rescued a 77-year-old woman ...
A single cycle of atezolizumab plus tiragolumab triggered simultaneous myocarditis, hepatitis, thrombocytopenia, and dermatomyositis in a lung cancer patient, whose ...
© 2026 Scienmag - Science Magazine
© 2026 Scienmag - Science Magazine